
Philip Kern
Director, Center for Clinical and Translational Sciences · University of Kentucky College of Medicine
Credentials: · · · · ·
History
PresentCenter for Clinical and Translational Sciences · University of Kentucky College of Medicine
PresentCenter for Clinical and Translational Science – Department of Internal Medicine · University of Kentucky College of Medicine


- 1978–1981
Internal Medicine
- 1974–1978
Research
American Journal of Physiology-Endocrinology and Metabolism · 2001 · First of 5 authors · Corresponding · 1,381 citations
Journal of Clinical Investigation · 1995 · First of 6 authors · 1,062 citations
Diabetes · 2003 · First of 5 authors · Corresponding · 677 citations

39 papers
- SE
12 papers

7 papers

7 papers
- BS
6 papers
- TS
5 papers
- LR
4 papers
- LF
4 papers
Grants
- 2025–2030
University of Kentucky Diabetes Prevention COBRE
National Institute of General Medical Sciences · P20
Project lead · $534.2K · University of Kentucky
- 2025–2030
The MiLC Study: Moringa in Lactation and Early Childhood
National Institute of Child Health and Human Development · R01
Contact PI · $1.2M · University of Kentucky
- 2024–2029
Epitranscriptomics in Human Obesity and Type 2 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases · RC2
PI · $6M · Joslin Diabetes Center
- 2024–2028
NIH Office of the Director · C06
Contact PI · $7.5M · University of Kentucky
Clinical trials
- 2021–2027
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
Principal investigator · Recruiting · Phase 4
Philip Kern
- 2020–2027
Mechanisms for Activation of Beige Adipose Tissue in Humans
Principal investigator · Recruiting · Phase 2
Philip Kern
- 2016–2019
- 2016–2018

